PATH Blog Examines Organization’s Work In Malaria Through Affiliate Drug Development Program
This PATH Blog post examines PATH’s work in malaria through OneWorld Health, a non-profit drug development program. Since 2004, “when OneWorld Health formed a partnership to develop an alternative source of the malaria drug artemisinin, … OneWorld Health, which became an affiliate of PATH late last year, [has] quietly forged relationships with public and private partners, creating the Artemisinin Project to take the work from research to commercialization,” the blog writes. “Supported by the Bill & Melinda Gates Foundation, the partners worked toward providing an affordable and reliable source of high-quality artemisinin — one not dependent on planting schedules, the weather, or the fluctuating market,” the blog adds (Donnelly, 4/10).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.